SILINI, ENRICO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.920
AS - Asia 1.931
EU - Europa 1.516
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 57
OC - Oceania 4
AN - Antartide 1
Totale 6.739
Nazione #
US - Stati Uniti d'America 2.811
CN - Cina 1.023
SG - Singapore 373
IE - Irlanda 342
DE - Germania 211
UA - Ucraina 207
FI - Finlandia 183
HK - Hong Kong 181
BR - Brasile 179
VN - Vietnam 152
RU - Federazione Russa 149
FR - Francia 102
IT - Italia 95
SE - Svezia 84
GB - Regno Unito 79
CA - Canada 51
IN - India 37
JP - Giappone 32
BD - Bangladesh 25
IQ - Iraq 18
AR - Argentina 17
MX - Messico 16
ZA - Sudafrica 15
PL - Polonia 13
CO - Colombia 11
ID - Indonesia 11
IL - Israele 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
VE - Venezuela 10
MA - Marocco 8
SA - Arabia Saudita 8
CR - Costa Rica 7
EC - Ecuador 7
TR - Turchia 7
CL - Cile 6
LT - Lituania 6
PK - Pakistan 6
PR - Porto Rico 6
BE - Belgio 5
GP - Guadalupe 5
NI - Nicaragua 5
NL - Olanda 5
PH - Filippine 5
PY - Paraguay 5
SV - El Salvador 5
DZ - Algeria 4
ES - Italia 4
KE - Kenya 4
MY - Malesia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AT - Austria 3
AZ - Azerbaigian 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
SC - Seychelles 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
IR - Iran 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
Totale 6.668
Città #
Dublin 342
Chandler 335
Ashburn 320
Jacksonville 297
Nanjing 239
San Jose 233
Beijing 181
Hong Kong 178
Singapore 172
Council Bluffs 160
Dallas 128
Boardman 99
Nanchang 88
Princeton 71
Hebei 68
Lawrence 63
Lauterbourg 61
Shenyang 60
Wilmington 59
Los Angeles 57
Jiaxing 51
Changsha 50
Munich 50
Tianjin 48
Hanoi 41
Hangzhou 40
Ho Chi Minh City 40
Medford 38
Moscow 34
Helsinki 33
Tokyo 31
New York 29
Buffalo 26
Milan 26
Santa Clara 26
Orem 25
Shanghai 24
Ann Arbor 23
Redondo Beach 21
Toronto 21
Turku 19
Verona 18
Brooklyn 15
Norwalk 15
São Paulo 15
Frankfurt am Main 14
Montreal 13
Johannesburg 12
Warsaw 12
Woodbridge 12
Jinan 10
Tashkent 10
Baghdad 9
Chicago 9
Haiphong 9
Kunming 9
Brno 8
Chennai 8
Des Moines 8
Stockholm 8
Auburn Hills 7
Guangzhou 7
Mexico City 7
Seattle 7
The Dalles 7
Biên Hòa 6
Boston 6
Dearborn 6
Dong Ket 6
Manchester 6
Phoenix 6
San Francisco 6
Zhengzhou 6
Brussels 5
Charlotte 5
Da Nang 5
Houston 5
London 5
Managua 5
Newark 5
Rome 5
Agadir 4
Amsterdam 4
Atlanta 4
Bogotá 4
Buenos Aires 4
Columbus 4
Curitiba 4
Denver 4
Falkenstein 4
Falls Church 4
Las Vegas 4
Mumbai 4
Nairobi 4
Rio de Janeiro 4
San Diego 4
Washington 4
Addis Ababa 3
Asunción 3
Baku 3
Totale 4.317
Nome #
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 151
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 147
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 145
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 137
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 137
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 132
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 130
Comparative evaluation of two serological typing methods for hepatitis C virus 128
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 126
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 125
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 124
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 122
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 120
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 119
Clinical significance of hepatitis C virus genotypes. 118
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 118
Su di uno "strano" epatocarcinoma 117
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 117
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 116
HCV viremia in hemodialysis patients 116
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 115
Comparative evaluation of two serologic typing methods of hepatitis C virus 113
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 113
Association between class II allelles and protection or susceptibility to chronic hepatitis C 111
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 107
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 107
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 105
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 104
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 104
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 103
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 101
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 101
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 101
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 99
Virological feaures of hepatitis C virus infection in hemodialysis patients 97
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 97
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 96
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 95
Different spectrum of liver disease in patients with HCV genotype II and III infection 95
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 94
HLA genes and chronic hepatitis C severity 94
Comparative evaluation of HCV core genotyping and serotyping 94
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 93
Hepatitis C virus core serotypes in haemodialysis patients 92
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 92
Virological features of HCV infection in hemodialysis patients 91
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 91
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 90
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 90
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 88
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 88
HVR1 variation, viral type and ALT values in chronic HCV infection 87
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 82
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 81
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 77
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 77
Molecular epidemiology of HCV infection in drug addicts 75
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 75
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 74
Vertical trasnmission of hepatitis C 72
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 72
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 71
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 71
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 66
Significance of hepatitis C virus genotypes 66
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 57
null 30
Totale 6.739
Categoria #
all - tutte 28.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 0 0 0 0 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024266 23 55 6 32 27 57 1 23 1 6 9 26
2024/2025797 30 76 40 28 2 18 34 43 197 17 127 185
2025/20261.968 168 212 188 209 241 89 350 53 209 137 60 52
2026/2027661 39 100 146 251 125 0 0 0 0 0 0 0
Totale 6.739